Proteomic, microarray, and signature-tagged mutagenesis analyses of anaerobic Pseudomonas aeruginosa at pH 6.5, likely representing chronic, late-stage cystic fibrosis airway conditions.

Journal of Bacteriology
Mark D PlattD J Hassett

Abstract

Patients suffering from cystic fibrosis (CF) commonly harbor the important pathogen Pseudomonas aeruginosa in their airways. During chronic late-stage CF, P. aeruginosa is known to grow under reduced oxygen tension and is even capable of respiring anaerobically within the thickened airway mucus, at a pH of approximately 6.5. Therefore, proteins involved in anaerobic metabolism represent potentially important targets for therapeutic intervention. In this study, the clinically relevant "anaerobiome" or "proteogenome" of P. aeruginosa was assessed. First, two different proteomic approaches were used to identify proteins differentially expressed under anaerobic versus aerobic conditions. Microarray studies were also performed, and in general, the anaerobic transcriptome was in agreement with the proteomic results. However, we found that a major portion of the most upregulated genes in the presence of NO(3)(-) and NO(2)(-) are those encoding Pf1 bacteriophage. With anaerobic NO(2)(-), the most downregulated genes are those involved postglycolytically and include many tricarboxylic acid cycle genes and those involved in the electron transport chain, especially those encoding the NADH dehydrogenase I complex. Finally, a signature-tagg...Continue Reading

References

Aug 1, 1978·Applied and Environmental Microbiology·D R WilliamsR G Eagon
Mar 1, 1993·Archives of Biochemistry and Biophysics·S I Liochev, I Fridovich
Mar 1, 1996·Analytical Chemistry·A ShevchenkoM Mann
Nov 15, 1996·FEMS Microbiology Letters·A G MatthysseA E Goodman
Oct 6, 1997·The Journal of Biological Chemistry·P R GardnerA L Salzman
Apr 2, 1999·Antimicrobial Agents and Chemotherapy·M P Mingeot-LeclercqP M Tulkens
Feb 13, 2001·Journal of Bacteriology·P BrannyC Van Delden
Oct 6, 2001·Current Opinion in Microbiology·D E LehouxR C Levesque
Feb 6, 2002·The Journal of Clinical Investigation·Dieter WorlitzschGerd Döring
Mar 20, 2003·Journal of Bacteriology·Victoria E WagnerBarbara H Iglewski
May 31, 2003·Journal of Bacteriology·Florence JudeChristian van Delden
Jul 18, 2003·Journal of Bacteriology·Jeremy S WebbStaffan Kjelleberg
Dec 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Raymond D CoakleyRichard C Boucher
Jun 25, 2004·Antimicrobial Agents and Chemotherapy·Giorgia BorrielloPhilip S Stewart
May 24, 2005·Infection and Immunity·M J FiliatraultL Passador
Nov 18, 2005·Journal of Bacteriology·Christopher J Southey-PilligKarin Sauer
Dec 27, 2005·Antimicrobial Agents and Chemotherapy·Giorgia BorrielloPhilip S Stewart
Jan 28, 2006·The Journal of Clinical Investigation·Sang Sun YoonDaniel J Hassett

❮ Previous
Next ❯

Citations

May 21, 2013·Enzyme and Microbial Technology·Hongliang GuoNanqi Ren
Jul 30, 2008·Antimicrobial Agents and Chemotherapy·Irith WiegandRobert E W Hancock
May 4, 2011·Antimicrobial Agents and Chemotherapy·Mohamad A HamadMartin I Voskuil
Dec 9, 2008·Journal of Bacteriology·Richard D Waite, Michael A Curtis
May 15, 2013·Journal of Bacteriology·Angelyca A JacksonDeborah A Hogan
Jan 22, 2011·BMC Genomics·Vincent M Isabella, Virginia L Clark
Oct 27, 2011·PLoS Pathogens·Sasan AminiSaeed Tavazoie
Aug 19, 2014·International Journal of Medical Microbiology : IJMM·Anja EichnerMichael Hogardt
Jun 26, 2009·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Francesca CutruzzolàMaurizio Brunori
Jul 29, 2010·Molecular Microbiology·Jeffrey W SchertzerMarvin Whiteley
Jun 18, 2010·Environmental Microbiology·Katharina TrunkDieter Jahn
Dec 8, 2010·Proteomics. Clinical Applications·Nathan J Hare, Stuart J Cordwell
Mar 20, 2010·Environmental Microbiology·Aurélie CrabbéPierre Cornelis
Oct 24, 2009·Microbiology·Mathias MüskenSusanne Häussler
Nov 25, 2014·Proteomics. Clinical Applications·Karthik Shantharam KamathMark P Molloy
Feb 12, 2015·FEMS Microbiology Reviews·Anne Mai-ProchnowScott A Rice
Apr 27, 2016·Environmental Science & Technology·Shu-Hong GaoPhilip L Bond
Nov 17, 2015·Cell Host & Microbe·Patrick R SecorPaul L Bollyky
Sep 1, 2017·Microbial Biotechnology·José Manuel Borrero-de AcuñaDieter Jahn
Jun 17, 2015·Journal of Bacteriology·John H HammondDeborah A Hogan
Jan 15, 2014·Integrative Biology : Quantitative Biosciences From Nano to Macro·Feng Q HeAn-Ping Zeng
Apr 7, 2019·EMBO Reports·Iain D Hay, Trevor Lithgow
Sep 19, 2019·Journal of Bacteriology·Alex W CrockerDeborah A Hogan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.